NM_001127649.3:c.254dupT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001127649.3(PEX26):c.254dupT(p.Cys86ValfsTer29) variant causes a frameshift change. The variant allele was found at a frequency of 0.000013 in 1,461,882 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L85L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001127649.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- peroxisome biogenesis disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- peroxisome biogenesis disorder 7A (Zellweger)Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- peroxisome biogenesis disorder 7BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
- Zellweger spectrum disordersInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001127649.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX26 | NM_001127649.3 | MANE Select | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 2 of 5 | NP_001121121.1 | ||
| PEX26 | NM_017929.6 | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 3 of 6 | NP_060399.1 | |||
| PEX26 | NM_001199319.2 | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 3 of 5 | NP_001186248.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PEX26 | ENST00000399744.8 | TSL:1 MANE Select | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 2 of 5 | ENSP00000382648.4 | ||
| PEX26 | ENST00000329627.11 | TSL:1 | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 3 of 6 | ENSP00000331106.5 | ||
| PEX26 | ENST00000428061.2 | TSL:1 | c.254dupT | p.Cys86ValfsTer29 | frameshift | Exon 2 of 4 | ENSP00000412441.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251490 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder 7A (Zellweger) Pathogenic:2
Peroxisome biogenesis disorder 7B;C3888385:Peroxisome biogenesis disorder 7A (Zellweger) Pathogenic:1
This sequence change creates a premature translational stop signal (p.Cys86Valfs*29) in the PEX26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX26 are known to be pathogenic (PMID: 12851857, 21031596). This variant is present in population databases (rs779824948, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with Zellweger spectrum disorder (PMID: 12851857). ClinVar contains an entry for this variant (Variation ID: 2158). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects PEX26 function (PMID: 12851857, 16257970). For these reasons, this variant has been classified as Pathogenic.
Peroxisome biogenesis disorder 7B Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at